Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 42385-915

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 42385-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Container Label (30's count))

Each film-coated tablet of this medicine contains 600mg of Efavirenz USP, 200mg of Emtricitabine, and 300mg of Tenofovir Disoproxil Fumarate, equivalent to 245mg of Tenofovir Disoproxil. The usual dosage and administration should be followed as per the package insert. The medicine should be stored in its original container at a temperature between 20°C to 25°C, with excursions permitted between 15°C to 30°C. It is not recommended to take this medicine with certain other medications. This medicine is manufactured by Laurus Labs Limited in Visakhapatnam.*

FDA Label Image

Efavirenz-structure (Efavirenz Structure)

FDA Label Image

Emtricitabine-structure (Emtricitabine Structure)

FDA Label Image

Tenofovir-structure (Tenofovir Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.